Alkermes plc. Operating Lease, Weighted Average Discount Rate, Percent
Alkermes plc. (ALKS) had Operating Lease, Weighted Average Discount Rate, Percent of 3.50% as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-07-28
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 3.50%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 3.60%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 3.60%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 3.70%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2026-06-30 | 3.50% 10-Q · filed 2026-07-28 | |
| 2026-03-31 | 3.60% 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 3.60% 10-K · filed 2026-02-25 | |
| 2025-09-30 | 3.70% 10-Q · filed 2025-10-28 | |
| 2025-06-30 | 3.80% 10-Q · filed 2025-07-29 | |
| 2025-03-31 | 3.90% 10-Q · filed 2025-05-01 | |
| 2024-12-31 | 4.00% 10-K · filed 2026-02-25 | |
| 2024-09-30 | 4.10% 10-Q · filed 2024-10-24 | |
| 2024-06-30 | 4.20% 10-Q · filed 2024-07-24 | |
| 2024-03-31 | 4.30% 10-Q · filed 2024-05-01 | |
| 2023-12-31 | 4.40% 10-K · filed 2025-02-12 | |
| 2023-09-30 | 5.30% 10-Q · filed 2023-10-25 | |
| 2023-06-30 | 5.30% 10-Q · filed 2023-07-26 | |
| 2023-03-31 | 5.27% 10-Q · filed 2023-04-26 | |
| 2022-12-31 | 5.50% 10-K · filed 2024-02-21 | 5.25% 10-K · filed 2023-02-16 |
| 2022-09-30 | 5.23% 10-Q · filed 2022-11-02 | |
| 2022-06-30 | 5.21% 10-Q · filed 2022-07-27 | |
| 2022-03-31 | 5.19% 10-Q · filed 2022-04-27 | |
| 2021-12-31 | 5.25% 10-K · filed 2023-02-16 | |
| 2021-09-30 | 5.27% 10-Q · filed 2021-10-27 | |
| 2021-06-30 | 5.26% 10-Q · filed 2021-07-28 | |
| 2021-03-31 | 5.25% 10-Q · filed 2021-04-28 | |
| 2020-12-31 | 5.25% 10-K · filed 2021-02-11 | |
| 2020-09-30 | 5.58% 10-Q · filed 2020-10-29 | |
| 2020-06-30 | 5.57% 10-Q · filed 2020-07-29 | |
| 2020-03-31 | 5.55% 10-Q · filed 2020-04-29 | |
| 2019-12-31 | 4.73% 10-K · filed 2020-02-13 | |
| 2019-09-30 | 4.71% 10-Q · filed 2019-10-23 | |
| 2019-06-30 | 4.64% 10-Q · filed 2019-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |